Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
1,950
NCT00752960
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2007
Completion: Dec 31, 2009
NCT00767130
DNA Diagnostic System for Statin Safety and Efficacy
NCT02345356
A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
Role: Collaborator
Start: Jan 31, 2016
Completion: May 17, 2022